北京大学学报(医学版) ›› 2020, Vol. 52 ›› Issue (4): 688-691. doi: 10.19723/j.issn.1671-167X.2020.04.017

• 论著 • 上一篇    下一篇

个体化尿量控制提高泌尿肿瘤放疗期间膀胱稳定性

王皓1,姜树坤1,彭冉1,黄毅2,(),王明清1,王俊杰1,刘承2,张帆2,马潞林2   

  1. 1.北京大学第三医院 肿瘤放疗科,北京 100191
    2.北京大学第三医院 泌尿外科,北京 100191
  • 收稿日期:2020-03-16 出版日期:2020-08-18 发布日期:2020-08-06
  • 通讯作者: 黄毅 E-mail:pku_huang@163.com
  • 基金资助:
    北京大学第三医院临床重点项目创新项目类(BYSY2018012)

Individual control of urine volume to improve stability of bladder volume in radiotherapy of urinary tumor

Hao WANG1,Shu-kun JIANG1,Ran PENG1,Yi HUANG2,(),Ming-qing WANG1,Jun-jie WANG1,Cheng LIU2,Fan ZHANG2,Lu-lin MA2   

  1. 1. Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, China
    2. Department of Urology, Peking University Third Hospital, Beijing 100191, China
  • Received:2020-03-16 Online:2020-08-18 Published:2020-08-06
  • Contact: Yi HUANG E-mail:pku_huang@163.com
  • Supported by:
    Clinical Key Projects of Peking University Third Hospital(BYSY2018012)

摘要:

目的: 探索个体化尿量控制训练模式,以个体化预期尿量为患者膀胱管控的目标,指导泌尿系统肿瘤患者主动感知膀胱容受性,提高放疗期间膀胱管控的精准度。方法: 选择2019年5月—9月北京大学第三医院收治的25例泌尿系统肿瘤患者。放疗定位前进行憋尿训练,要求患者以个体化膀胱适度充盈为训练目的,建议最佳的膀胱容量范围200~400 mL。训练2~4周后根据患者个体化的膀胱容受性确定放疗定位条件和放疗实施时的膀胱处方体积。患者CT模拟定位时采集平扫CT图像和静脉注射造影剂后8 min图像,分别测量膀胱体积。患者治疗前自评膀胱体积接近膀胱处方体积时使用膀胱容量测量仪测量体积,治疗前行锥形束计算机断层扫描(cone beam computed tomography,CBCT)并测量膀胱体积,治疗结束后再次使用膀胱仪测量膀胱体积。结果: 放疗前自评膀胱体积(VEVA01)与放疗前膀胱仪测量体积(VBVI01)、定位CT测量膀胱体积(VCT01)与放疗前膀胱仪测量体积(VBVI01)、定位CT测量膀胱体积(VCT01)与CBCT测量膀胱体积(VCBCT)存在相关性,配对样本t检验差异无统计学意义。定位CT体积(VCT01)与放疗前自评膀胱体积(VEVA01)、放疗前自评膀胱体积(VEVA01)与CBCT体积(VCBCT)存在相关性,配对t检验差异无统计学意义。结论: 前列腺癌和膀胱癌等泌尿系统肿瘤放疗期间,在膀胱容量测量仪的辅助下尝试让患者根据自身情况适度憋尿,个体化膀胱处方可能有利于实现放疗期间稳定的膀胱体积。

关键词: 膀胱体积, 放射治疗, 泌尿肿瘤, 超声扫描

Abstract:

Objective: To explore the training mode of individual urine volume control, to take indi-vidual expected urine volume as the goal of bladder control in patients with urinary system tumors, and to improve the accuracy of bladder control during radiotherapy by active training of bladder receptivity. Methods: Twenty-five patients of urinary system tumors were enrolled from May 2019 to September 2019, of whom, 21 patients had prostate cancer, and 4 had bladder cancer. Training of bladder filling started before CT simulation. The patients were required to take the individual bladder filling as the training goal, and the optimal bladder volume range was suggested to be 200-400 mL. After 2-4 weeks of training, the prescribed volume of the bladder was determined according to the patient’s bladder receptivity. The volume of the bladder was measured by images of plain CT and images 8-minutes after intravenous contrast injection. The patient’s bladder volume was measured using BladderScan before treatment. CBCT (Cone-beam CT) was performed, and bladder volume was measured before treatment. The bladder volume was measured again using BladderScan after treatment. Results: The mean bladder volume of simulation (VCT01) was (262±130) mL, ranging from 78 mL to 505 mL. The mean self-evaluation bladder volume before radiotherapy (VEVA01) was (238±107) mL, ranging from 100 mL to 400 mL. The mean BladderScan measured volume before radiotherapy (VBVI01) was (253±123) mL, ranging from 60 mL to 476 mL. The mean cone-beam CT measured volume before radiotherapy (VCBCT) was (270±120) mL, ranging from 104 mL to 513 mL. There was a correlation between VEVA01 and VBVI01, VCT01 and VBVI01, VCT01, and VBVI01, and there was no significant difference in paired t-test. There was a correlation between differences of self-evaluation bladder volume before radiotherapy(VEVA01) and simulation CT (VCT01) and differences of self-evaluation bladder volume before radiotherapy (VEVA01) and cone-beam CT (VCBCT), and there was no significant difference in paired samples by t-test. Conclusion: During radiotherapy for urinary system tumors, such as prostate cancer and bladder cancer, with the assistance of BladderScan, the patients could try to hold their urine moderately according to their conditions, and individualized bladder prescription may be beneficial to achieve stable bladder volume during radiotherapy.

Key words: Bladder volume, Radiotherapy, Urinary system tumor, Ultrasound scanner

中图分类号: 

  • R737

表1

膀胱测量仪与定位CT和CBCT膀胱体积的分析结果"

Items Correlation analysis Paired t test
Correlation index P value t value P value 95%CI
VCT01 vs. VBVI01 0.915 <0.001 0.890 0.382 -12.295-30.935
VBVI01 vs. VCBCT 0.940 <0.001 -2.506 0.081 -34.947-6.712
VCT01 vs. VCBCT 0.912 <0.001 -0.762 0.453 -30.099-13.859

表2

膀胱测量仪与定位CT和CBCT膀胱体积的分析结果"

Items Correlation analysis Paired t test
Correlation index P value t value P value 95%CI
VCT01-VBVI01 vs. VCT01-VCBCT 0.480 0.015 -0.431 0.670 -19.449- 12.729
VCT01-VBVI01 vs. VCBCT-VBVI01 0.226 0.277 -0.272 0.788 -19.566-15.006
VCT01-VCT02 vs. VBVI01-VBVI02 0.595 0.002 1.642 0.114 -3.235-28.435
[1] Rebecca LS, Kimberly DM, Ahmedin JD, et al. Cancer statistics[J]. CA Cancer J Clin, 2020,70(1):7-30.
pmid: 31912902
[2] Scott CM, Karen H, Andrew L, et al. Hypofractionated radiation therapy for localized prostate cancer: an ASTRO, ASCO, and AUA evidence-based guideline[J]. J Clin Oncol, 2018,36(34):3411-3430.
[3] Chen Z, Yang ZZ, Wang JZ, et al. Dosimetric impact of different bladder and rectum filling during prostate cancer radiotherapy[J]. Radiat Oncol, 2016,11(103):1-8.
[4] Heng SP, Low SH, Sivamany K. The influence of the bowel and bladder preparation protocol for radiotherapy of prostate cancer using kilo-voltage cone beam CT: our experience[J]. Indian J Cancer, 2015,52(4):639-644.
[5] 穆娅莎·阿布力米提, 周卫兵, 刘海峰, 等. 盆腔肿瘤患者放疗前膀胱充盈稳定性训练及可靠性研究[J]. 中华放射肿瘤学杂志, 2016,25(2):146-149.
[6] 姜晓勃, 钟庆初, 黄群峰, 等. 盆腔肿瘤放疗中膀胱充盈一致性初步研究[J]. 中华放射肿瘤学杂志, 2016,25(6):598-601.
[7] Oscar CM, Vitali M, Austin H, et al. Associations between volume changes and spatial dose metrics for the urinary bladder durin local vs. pelvic irradiation for prostate cancer[J]. Acta Oncol, 2017,56(6):884-890.
[8] Rex C, Susan LT, Lei D, et al. Investigation of bladder dose and volume factors influencing late urinary toxicity after external beam radiotherapy for prostate cancer[J]. Int J Radiat Oncol Biol Phys, 2007,67(4):1059-1065.
doi: 10.1016/j.ijrobp.2006.10.042 pmid: 17241755
[9] 毛睿, 何艳芬, 齐洪志, 等. 膀胱充盈状态对宫颈癌术后调强放疗靶区和危及器官的影响[J]. 中华实用诊断与治疗杂志, 2013,27(8):794-796.
[10] 任雪, 阎英, 徐莹, 等. 不同膀胱充盈度对前列腺癌放疗影响[J]. 临床军医杂志, 2018,46(4):439-441.
[11] Akila NV, Ellen DY, Lawrence BM, et al. Radiation dose-volume effects of the urinary bladder[J]. Int J Radiat Oncol Biol Phys, 2010,76(Suppl 3):S116-S122.
[12] Chang JS, Yoon HI, Cha HJ, et al. Bladder filling variations during concurrent chemotherapy and pelvic radiotherapy in rectal cancer patients: early experience of bladder volume assessment using ultrasound scanner[J]. Radiat Oncol J, 2013,31(1):41-47.
pmid: 23620868
[13] Mahantshetty U, Deepak PK, Pranav C, et al. Transabdominal ultrasonography-defined optimal and definitive bladder-filling protocol with time trends during pelvic radiation for cervical cancer[J]. Technol Cancer Res Treat, 2017,16(6):917-922.
doi: 10.1177/1533034617709596 pmid: 28532243
[14] Hong IY, Yoonsun C, Jee SC, et al. Evaluating variations of bladder volume using an ultrasound scanner in rectal cancer patients during chemoradiation: is protocol-based full bladder maintenance using a bladder scanner useful to maintain the bladder volume[J]. PLoS One, 2015,10(6):e0128791.
[15] Leah C, Vanessa C, Maree W, et al. Use of a prospective cohort study in the development of a bladder scanning protocol to assist in bladder filling consistency for prostate cancer patients receiving radiation therapy[J]. J Med Radiat Sci, 2016,63(3):179-185.
[1] 郭福新,姜玉良,吉喆,彭冉,孙海涛,王俊杰. 3D打印非共面模板辅助CT引导125Ⅰ粒子植入治疗锁骨上复发转移癌的剂量学研究[J]. 北京大学学报(医学版), 2017, 49(3): 506-511.
[2] 王庆国,李晓梅,张敏,李航,温冰,李洪振,高献书. 107例瘢痕疙瘩术后两种分割剂量放疗疗效分析[J]. 北京大学学报(医学版), 2014, 46(1): 169-172.
[3] 武金玉, 陈敏华, 严昆, 张晖, 王惠莉, 霍苓, 杨薇, 宋一平. 超声引导射频消融术应用于治疗肝转移癌[J]. 北京大学学报(医学版), 2001, 33(5): 449-451.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 田增民, 陈涛, Nanbert ZHONG, 李志超, 尹丰, 刘爽. 神经干细胞移植治疗遗传性小脑萎缩的临床研究(英文稿)[J]. 北京大学学报(医学版), 2009, 41(4): 456 -458 .
[2] 郭岩, 谢铮. 用一代人时间弥合差距——健康社会决定因素理论及其国际经验[J]. 北京大学学报(医学版), 2009, 41(2): 125 -128 .
[3] 成刚, 钱振华, 胡军. 艾滋病项目自愿咨询检测的技术效率分析[J]. 北京大学学报(医学版), 2009, 41(2): 135 -140 .
[4] 卢恬, 朱晓辉, 柳世庆, 郑杰, 邱晓彦. 白细胞介素2促进宫颈癌细胞系HeLaS3免疫球蛋白G的表达[J]. 北京大学学报(医学版), 2009, 41(2): 158 -161 .
[5] 袁惠燕, 张苑, 范田园. 离子交换型栓塞微球及其载平阳霉素的制备与性质研究[J]. 北京大学学报(医学版), 2009, 41(2): 217 -220 .
[6] 徐莉, 孟焕新, 张立, 陈智滨, 冯向辉, 释栋. 侵袭性牙周炎患者血清中抗牙龈卟啉单胞菌的IgG抗体水平的研究[J]. 北京大学学报(医学版), 2009, 41(1): 52 -55 .
[7] 祁琨, 邓芙蓉, 郭新彪. 纳米二氧化钛颗粒对人肺成纤维细胞缝隙连接通讯的影响[J]. 北京大学学报(医学版), 2009, 41(3): 297 -301 .
[8] Jian-wei GU, Emily YOUNG, Zhi-jun PAN, Kevan B. TUCKER, Megan SHPARAGO, Min HUANG, Amelia Purser BAILEY. SD大鼠长期高盐饮食可导致其高血压并改变肾细胞因子基因表达谱[J]. 北京大学学报(医学版), 2009, 41(5): 505 -515 .
[9] 李宏亮*, 安卫红*, 赵扬玉, 朱曦. 妊娠合并高脂血症性胰腺炎行血液净化治疗1例[J]. 北京大学学报(医学版), 2009, 41(5): 599 -601 .
[10] 李伟军, 邢晓芳, 曲立科, 孟麟, 寿成超. PRL-3基因C104S位点突变体和CAAX缺失体的构建及表达[J]. 北京大学学报(医学版), 2009, 41(5): 516 -520 .